In agreement, tumor xenografts established from colon cancer cells depleted of HIPK2 function, compared to control ones, showed that HIPK2 knockdown increases tumor vascularity and blood density, as evaluated by immunohistochemical analysis and by HIF-1α and VEGF up-regulation at the mRNA levels [85]. The gene discussed is HIPK2; the disease is malignant colon neoplasm.